DTPワクチンの世界市場レポート 2024

DTPワクチンの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.1%の年間複合成長率（CAGR）で86億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、強力な後期パイプラインの存在と新薬の承認、ヘルスケア費の増加、風土病の撲滅を目的とした予防接種政策の実施によるものと考えられます。予測期間の注目すべき動向には、混合ワクチンの開発への集中、研究開発活動への多額の投資、ワクチン開発における人工知能（AI）の利用、買収への戦略的焦点が含まれます。

世界中の政府は、病気の蔓延を抑制するためにDTPワクチンの開発を積極的に支持しています。結核、ポリオ、ジフテリア、破傷風、百日咳に対するワクチンを含む推奨ワクチンを国内のすべての子供に提供することを目的としたインドの普遍予防接種プログラムなどの取り組みが、定期的なワクチン接種推進に貢献しています。これらの取り組みは、予測期間の市場の成長にプラスの影響を与えると予想されます。

予想されるヘルスケア費の増加により、DTPワクチン市場の成長が促進されることになります。ヘルスケア支出には、ヘルスケア機器、病院サービス、医師サービス、処方薬、公衆衛生活動を含む、医療製品およびサービスに対する財政支出の総額が含まれます。ヘルスケア費の増加は、DTPワクチンの開発、生産、配布、効果的な利用に役立つ環境を促進する上で極めて重要な役割を果たします。たとえば、2023年 5月の国家統計局によると、英国では名目ヘルスケア支出が9.4%増加し、実質では9.7%増加しました。 2021年の英国のヘルスケア支出総額は3,672億5,000万米ドル（2,807億ポンド）に達し、医薬品支出は518億4,000万米ドル（396億ポンド）に達しました。さらに、予防医療支出は2021年に459億3,000万米ドル（351億ポンド）に急増し、前年の2倍以上となった。その結果、ヘルスケア費の増加がDTPワクチン市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のDTPワクチン市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• DTaP
• TD
• Tdap
• 世界のDTPワクチン市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ジフテリア
• 百日咳
• 破傷風
• 世界のDTPワクチン市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック
• 予防接種センター

第7章 地域および国の分析

• 世界のDTPワクチン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のDTPワクチン市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• DTPワクチン市場の競合情勢
• DTPワクチン市場の企業プロファイル
  • GlaxoSmithKline
  • Sanofi
  • Merck &Co Inc
  • Meiji Holdings Co., Ltd
  • Shenzhen Kangtai Biological Products

第31章 その他の大手および革新的な企業

• Serum Institute of India Pvt Ltd
• Sun Pharmaceutical Industries Ltd
• AJ Vaccines
• PT Bio Farma
• Bio Med
• Sinergium Biotech SA
• Teuto Brasileiro
• Amgen
• Roche
• BioFabri
• Sinopharm
• Chongqing Zhifei
• Hualan Biological Engineering Inc
• Ezequiel Dias Foundation（FUNED）
• BioKangtai

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Diphtheria, Tetanus, Pertussis (DTP) vaccines are combination vaccines administered intramuscularly to safeguard children under the age of 7 from diphtheria, tetanus, and whooping cough. These vaccines play a crucial role in conferring immunity to three bacterial diseases - diphtheria, tetanus, and pertussis - all of which can be life-threatening.

The primary product categories within DTP vaccines are DTaP, TD, and Tdap. DTaP vaccines are designed to help children under seven years of age develop immunity against three potentially deadly bacterial infections, diphtheria, pertussis (whooping cough), and tetanus. The diseases covered by these vaccines include diphtheria, pertussis, and tetanus, and they are administered in various healthcare settings such as hospitals, clinics, and vaccination centers.

The DTP vaccines market research report is one of a series of new reports from The Business Research Company that provides DTP vaccines market statistics, including global market size, regional shares, competitors with a DTP vaccines market share, detailed DTP vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the DTP vaccines industry. This DTP vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dtp vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be credited to an increase in access to healthcare, sustained efforts for protection against infectious diseases, and a rising awareness of immunization.

The dtp vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be ascribed to the presence of a robust late-stage pipeline and the approval of new drugs, a rise in healthcare expenditure, and the implementation of immunization policies aimed at eradicating endemic diseases. Notable trends in the forecast period encompass a concentration on the development of combination vaccines, substantial investment in research and development activities, the utilization of artificial intelligence (AI) in vaccine development, and a strategic focus on acquisitions.

Governments worldwide are actively endorsing the development of DTP vaccines to curb the spread of the disease. Initiatives such as India's Universal Immunization Program, designed to provide recommended vaccines, including those against tuberculosis, polio, diphtheria, tetanus, and whooping cough, for all children in the country, contribute to regular vaccination drives. These efforts are anticipated to have a positive impact on market growth in the forecast period.

The anticipated rise in healthcare expenditure is set to propel the DTP vaccine market's growth. Healthcare expenditure encompasses the total financial outlay on healthcare goods and services, covering medical equipment, hospital services, physician services, prescription drugs, and public health activities. Increased healthcare spending plays a pivotal role in fostering an environment conducive to the development, production, distribution, and effective utilization of DTP vaccines. For instance, according to the Office for National Statistics in May 2023, the UK experienced a 9.4% increase in nominal healthcare spending and a 9.7% rise in real terms. The total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion) in 2021, with pharmaceutical spending at $51.84 billion (£39.6 billion). Additionally, preventive care spending surged to $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Consequently, the upswing in healthcare expenditure is a driving force behind the expansion of the DTP vaccine market.

Prominent companies in the diphtheria, tetanus, and pertussis (DTP) vaccine market are dedicated to developing innovative vaccines such as BOOSTRIX to establish a competitive advantage. BOOSTRIX, introduced by GSK PLC, a UK-based biotechnology and pharmaceutical company, is a vaccine designed to protect adolescents (ages 10-18) and adults from diseases caused by Bordetella pertussis, diphtheria, and tetanus bacteria. As a combination vaccine, BOOSTRIX safeguards against whooping cough (pertussis), diphtheria, and tetanus. GSK plc received approval from the US Food and Drug Administration (FDA) for BOOSTRIX in October 2022, making it the first vaccine licensed specifically for use by pregnant women to shield unborn children from illness. Administered during pregnancy, it enhances the mother's antibodies, providing protection to the growing baby.

Companies within the DTP vaccines market are increasingly investing in the production of DTP combination vaccines, streamlining the immunization process against infectious diseases by reducing the need for multiple vaccination shots. Various DTP combination vaccines, such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent (DTP-Hib-HepB-IPV), offer equivalent protection compared to individual vaccines administered separately.

In August 2022, GSK plc executed a significant acquisition by purchasing Affinivax, Inc., a US-based biotechnology company, for $2.1 billion. This strategic move reinforces GSK's commitment to building a robust portfolio of specialized drugs and vaccines. Among the acquired assets is AFX3772, a candidate for the next-generation 24-valent pneumococcal vaccine, utilizing the groundbreaking Multiple Antigen Presenting System (MAPSTM) platform technology, currently in phase II development. Affinivax, Inc. specializes in developing preventative and therapeutic vaccines using an innovative approach to vaccine technology.

Major companies operating in the dtp vaccines market report are GlaxoSmithKline, Sanofi, Merck & Co Inc., Meiji Holdings Co., Ltd., Shenzhen Kangtai Biological Products, Serum Institute of India Pvt Ltd., Sun Pharmaceutical Industries Ltd., AJ Vaccines, PT Bio Farma, Bio Med, Sinergium Biotech SA, Teuto Brasileiro, Amgen, Roche, BioFabri, Sinopharm, Chongqing Zhifei, Hualan Biological Engineering Inc., Ezequiel Dias Foundation (FUNED), BioKangtai, Uniao Quimica, Valneva SE, The Abu Dhabi Health Services Company (SEHA), ImevaX GmbH, Cristalia, Bharat Biotech, Bio-Manguinhos-Institute of Technology on Immunobiologicals, Connaught Laboratories Inc., Biolab Farmaceutica, Massbiologics, Beijing Tiantan Biological Products Co Ltd., Butantan Institute, C.R.I. Kasauli, Bayer, Pfizer, Abbott Laboratories, Serum Institute of India Pvt Ltd., Novartis, Wyeth-Ayerst, Dano Vaccines, Merck Serono Middle East, Hypermarcas, AstraZeneca, Grifols, Sinovac Biotech Ltd., AbbVie Inc., Apotex, GreenSignal Bio Pharma Private Limited (GSBPL), Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG, Boehringer Ingelheim, CanSino Biologics, Gilead Sciences, Panacea Biotec Ltd., Fiocruz, Johnson & Johnson, Walvax biotechnology, BioNTech, EMS Pharma, Mylan, National Administration of Laboratories and Institutes of Health (ANLIS), Zentiva, Afrigen Biologics & Vaccines

North America was the largest region in the DTP vaccines market in 2023. The regions covered in the dtp vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dtp vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The DTP vaccine market consists of sales of Daptacel, Infanrix, Kinrix, Paediarix, Pentacel, Quadracel, and Vaxelis vaccines. Values in this market are 'factory gate values,' that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DTP Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dtp vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dtp vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dtp vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Blood Glucose Test Strips; Insulin Pens, Syringes, Pumps And Injectors; Lancing Devices And Equipment; Continuous Glucose Monitoring Devices And Equipment; Blood Glucose Meters
• 2) By Type of Expenditure: Public; Private
• 3) By Product: Instruments Or Equipment; Disposables
• 4) By Type Of Testing: Point Of Care (POC) Testing; Non-Point Of Care (POC) Testing
• 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
• Subsegments Covered: Glucose Dehydrogenase; Glucose Oxidase; Pens; Injectors And Pumps; Syringes
• Companies Mentioned: GlaxoSmithKline; Sanofi; Merck & Co Inc; Meiji Holdings Co., Ltd; Shenzhen Kangtai Biological Products
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DTP Vaccines Market Characteristics

3. DTP Vaccines Market Trends And Strategies

4. DTP Vaccines Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global DTP Vaccines Market Size and Growth

• 5.1. Global DTP Vaccines Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global DTP Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global DTP Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. DTP Vaccines Market Segmentation

• 6.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• DTaP
• TD
• Tdap
• 6.2. Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diphtheria
• Pertussis
• Tetanus.
• 6.3. Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Vaccination Centers

7. DTP Vaccines Market Regional And Country Analysis

• 7.1. Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific DTP Vaccines Market

• 8.1. Asia-Pacific DTP Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China DTP Vaccines Market

• 9.1. China DTP Vaccines Market Overview
• 9.2. China DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India DTP Vaccines Market

• 10.1. India DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan DTP Vaccines Market

• 11.1. Japan DTP Vaccines Market Overview
• 11.2. Japan DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia DTP Vaccines Market

• 12.1. Australia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia DTP Vaccines Market

• 13.1. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea DTP Vaccines Market

• 14.1. South Korea DTP Vaccines Market Overview
• 14.2. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe DTP Vaccines Market

• 15.1. Western Europe DTP Vaccines Market Overview
• 15.2. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK DTP Vaccines Market

• 16.1. UK DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany DTP Vaccines Market

• 17.1. Germany DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France DTP Vaccines Market

• 18.1. France DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy DTP Vaccines Market

• 19.1. Italy DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain DTP Vaccines Market

• 20.1. Spain DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe DTP Vaccines Market

• 21.1. Eastern Europe DTP Vaccines Market Overview
• 21.2. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia DTP Vaccines Market

• 22.1. Russia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America DTP Vaccines Market

• 23.1. North America DTP Vaccines Market Overview
• 23.2. North America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA DTP Vaccines Market

• 24.1. USA DTP Vaccines Market Overview
• 24.2. USA DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada DTP Vaccines Market

• 25.1. Canada DTP Vaccines Market Overview
• 25.2. Canada DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America DTP Vaccines Market

• 26.1. South America DTP Vaccines Market Overview
• 26.2. South America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil DTP Vaccines Market

• 27.1. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East DTP Vaccines Market

• 28.1. Middle East DTP Vaccines Market Overview
• 28.2. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa DTP Vaccines Market

• 29.1. Africa DTP Vaccines Market Overview
• 29.2. Africa DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. DTP Vaccines Market Competitive Landscape And Company Profiles

• 30.1. DTP Vaccines Market Competitive Landscape
• 30.2. DTP Vaccines Market Company Profiles
  • 30.2.1. GlaxoSmithKline
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Sanofi
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co Inc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Meiji Holdings Co., Ltd
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Shenzhen Kangtai Biological Products
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. DTP Vaccines Market Other Major And Innovative Companies

• 31.1. Serum Institute of India Pvt Ltd
• 31.2. Sun Pharmaceutical Industries Ltd
• 31.3. AJ Vaccines
• 31.4. PT Bio Farma
• 31.5. Bio Med
• 31.6. Sinergium Biotech SA
• 31.7. Teuto Brasileiro
• 31.8. Amgen
• 31.9. Roche
• 31.10. BioFabri
• 31.11. Sinopharm
• 31.12. Chongqing Zhifei
• 31.13. Hualan Biological Engineering Inc
• 31.14. Ezequiel Dias Foundation (FUNED)
• 31.15. BioKangtai

32. Global DTP Vaccines Market Competitive Benchmarking

33. Global DTP Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The DTP Vaccines Market

35. DTP Vaccines Market Future Outlook and Potential Analysis

• 35.1 DTP Vaccines Market In 2028 - Countries Offering Most New Opportunities
• 35.2 DTP Vaccines Market In 2028 - Segments Offering Most New Opportunities
• 35.3 DTP Vaccines Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer